| Emerging integrase strand transfer inhibitor drug resistance mutations among children and adults on ART in Tanzania: findings from a national representative HIV drug resistance … D Kamori, G Barabona, J Rugemalila, W Maokola, SS Masoud, ... Journal of Antimicrobial Chemotherapy 78 (3), 779-787, 2023 | 19 | 2023 |
| Pre-treatment and acquired HIV drug resistance in Dar es Salaam, Tanzania in the era of tenofovir and routine viral load monitoring G Barabona, M Mahiti, S Masoud, P Mbelele, AS Mgunya, L Minja, ... Journal of Antimicrobial Chemotherapy 74 (10), 3016-3020, 2019 | 16 | 2019 |
| Dissecting naturally arising amino acid substitutions at position L452 of SARS-CoV-2 spike TS Tan, M Toyoda, H Ode, G Barabona, H Hamana, M Kitamatsu, H Kishi, ... Journal of virology 96 (20), e01162-22, 2022 | 10 | 2022 |
| Circulating HIV-1 integrase genotypes in Tanzania: implication on the introduction of integrase inhibitors-based antiretroviral therapy regimen S Masoud, D Kamori, G Barabona, M Mahiti, B Sunguya, E Lyamuya, ... AIDS research and human retroviruses 36 (6), 539-543, 2020 | 9 | 2020 |
| HIV virologic response, patterns of drug resistance mutations and correlates among adolescents and young adults: A cross-sectional study in Tanzania J Rugemalila, D Kamori, P Kunambi, M Mizinduko, A Sabasaba, ... Plos one 18 (2), e0281528, 2023 | 7 | 2023 |
| Phenotypic and genotypic Co-receptor tropism testing in hiv-1 epidemic region of Tanzania where multiple non-b subtypes Co-circulate GP Judicate, G Barabona, D Kamori, M Mahiti, TS Tan, S Ozono, ... Frontiers in Microbiology 12, 703041, 2021 | 7 | 2021 |
| Hypertension and traditional risk factors for cardiovascular diseases among treatment naïve HIV-infected adults initiating antiretroviral therapy in Urban Tanzania TM Mwakyandile, GA Shayo, PG Sasi, FM Mugusi, G Barabona, T Ueno, ... BMC Cardiovascular Disorders 23 (1), 309, 2023 | 4 | 2023 |
| Dolutegravir resistance in sub-Saharan Africa: should resource-limited settings be concerned for future treatment? D Kamori, G Barabona Frontiers in Virology 3, 1253661, 2023 | 3 | 2023 |
| Evaluation of neutralizing activity against Omicron subvariants in BA. 5 breakthrough infection and three-dose vaccination using a novel chemiluminescence-based, virus-mediated … M Toyoda, TS Tan, C Motozono, G Barabona, A Yonekawa, N Shimono, ... Microbiology spectrum 11 (4), e00660-23, 2023 | 3 | 2023 |
| Relative resistance of patient-derived envelope sequences to SERINC5-mediated restriction of HIV-1 infectivity E Nkuwi, GP Judicate, TS Tan, G Barabona, M Toyoda, B Sunguya, ... Journal of Virology 97 (10), e00823-23, 2023 | 2 | 2023 |
| Acquired HIV drug resistance among children and adults receiving antiretroviral therapy in Tanzania: a national representative survey protocol J Rugemalila, D Kamori, W Maokola, M Mizinduko, G Barabona, ... BMJ open 11 (12), e054021, 2021 | 2 | 2021 |
| Advanced baseline immunosuppression is associated with elevated levels of plasma markers of fungal translocation and inflammation in long-term treated HIV-infected Tanzanians G Barabona, M Mahiti, M Toyoda, D Kamori, S Masoud, GP Judicate, ... AIDS Research and Therapy 18, 1-10, 2021 | 2 | 2021 |
| Seroprevalence of Human Herpesvirus Infections in Newly Diagnosed HIV‐Infected Key Populations in Dar es Salaam, Tanzania D Kamori, A Joachim, M Mizinduko, G Barabona, M Mahiti, U Kibwana, ... International Journal of Microbiology 2021 (1), 4608549, 2021 | 2 | 2021 |
| Neutralizing immunity against coronaviruses in Tanzanian health care workers G Barabona, I Ngare, D Kamori, L Nkinda, Y Kosugi, A Mawazo, R Ekwabi, ... Scientific reports 14 (1), 5508, 2024 | 1 | 2024 |
| Evaluation of cross‐neutralizing immunity following COVID‐19 primary series vaccination during the Omicron surge in Tanzania L Nkinda, G Barabona, I Ngare, E Nkuwi, D Kamori, F Msafiri, ... Journal of Medical Virology 96 (8), e29822, 2024 | | 2024 |
| Hypertension and immune activation in antiretroviral therapy naïve people living with human immunodeficiency virus TM Mwakyandile, GA Shayo, PG Sasi, FM Mugusi, G Barabona, T Ueno, ... BMC Infectious Diseases 24 (1), 630, 2024 | | 2024 |
| Factors Associated with Neutralizing Antibody Responses following 2-Dose and 3rd Booster Monovalent COVID-19 Vaccination in Japanese People Living with HIV I Ngare, TS Tan, M Toyoda, T Kuwata, S Takahama, E Nakashima, ... Viruses 16 (4), 555, 2024 | | 2024 |
| Erratum for Tan et al.,“Dissecting Naturally Arising Amino Acid Substitutions at Position L452 of SARS-CoV-2 Spike” TS Tan, M Toyoda, H Ode, G Barabona, H Hamana, M Kitamatsu, H Kishi, ... Journal of Virology 96 (23), e01737-22, 2022 | | 2022 |
| Advanced baseline immunosuppression is associated with elevated levels of plasma markers of fungal translocation and inflammation in long-term treated HIV-infected Tanzanians. T Ueno, G Barabona, M Mahiti, M Toyoda, D Kamori, S Masoud, ... | | 2021 |
| Acquired HIV Drug Resistance among Children and Adults Receiving Antiretroviral Therapy in Tanzania: A National Representative Survey Protocol D Kamori, M Mizinduko, G Barabona, S Masoud, L Mlunde, R Mutagonda, ... | | 2021 |
Takamasa UenoKumamoto University, Professor在 kumamoto-u.ac.jp 的电子邮件经过验证
